News

Sarepta Stock Sinks. How Its Crisis Went From Bad to Worse.
Most investors don’t see the drugmaker’s executive management as credible, following the failure to disclose a patient death, ...
The Manila Times4m
Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq
Connect Biopharma Holdings Limited (Nasdaq: CNTB) ('Connect Biopharma” or the 'Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory ...
InvestorsHub on MSN23m
ProMIS Neurosciences stock price surges in pre market trading as company receives FDA fast track designation for alzheimer’s drug candidate PMN310
ProMIS Neurosciences Inc. (Nasdaq:PMN), a clinical-stage biotechnology firm specializing in treatments for neurodegenerative ...
WUSF Public Media22m
Many beauty products have toxic ingredients. Newly proposed bills could change that
The "Safer Beauty Bill Package" would ban the most toxic ingredients in everyday cosmetics and create protections for the ...